3.405
price up icon4.77%   0.155
 
loading
Precedente Chiudi:
$3.25
Aprire:
$3.3
Volume 24 ore:
38,892
Relative Volume:
0.59
Capitalizzazione di mercato:
$100.60M
Reddito:
$4.01M
Utile/perdita netta:
$-35.01M
Rapporto P/E:
-2.9353
EPS:
-1.16
Flusso di cassa netto:
$-24.53M
1 W Prestazione:
-5.68%
1M Prestazione:
-22.96%
6M Prestazione:
-45.17%
1 anno Prestazione:
-37.75%
Intervallo 1D:
Value
$3.27
$3.47
Intervallo di 1 settimana:
Value
$3.22
$3.69
Portata 52W:
Value
$3.22
$9.96

Xbiotech Inc Stock (XBIT) Company Profile

Name
Nome
Xbiotech Inc
Name
Telefono
512-386-2900
Name
Indirizzo
5217 WINNEBAGO LANE, AUSTIN, TX
Name
Dipendente
92
Name
Cinguettio
@xbiotech_usa
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
XBIT's Discussions on Twitter

Confronta XBIT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
XBIT
Xbiotech Inc
3.40 100.60M 4.01M -35.01M -24.53M -1.16
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
490.86 125.43B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
719.42 76.60B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
670.21 39.57B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
275.13 35.33B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
122.82 28.08B 3.30B -501.07M 1.03B -2.1146

Xbiotech Inc Stock (XBIT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2019-06-14 Iniziato Piper Jaffray Overweight
2017-04-21 Downgrade Noble Financial Buy → Hold
2016-06-28 Reiterato Noble Financial Buy

Xbiotech Inc Borsa (XBIT) Ultime notizie

pulisher
Feb 04, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire

Feb 04, 2025
pulisher
Jan 30, 2025

XBiotech stock hits 52-week low at $3.5 amid market challenges - MSN

Jan 30, 2025
pulisher
Jan 27, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating XBiotech Inc. (XBIT) And Encourages Shareholders to Connect - Markets Insider

Jan 27, 2025
pulisher
Jan 27, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Shareholders to Reach Out - Markets Insider

Jan 27, 2025
pulisher
Jan 22, 2025

Barclays PLC Boosts Stock Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages XBiotech Inc. (XBIT) Stockholders to Inquire about Securities Investigation - Markets Insider

Jan 21, 2025
pulisher
Jan 20, 2025

XBIT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into XBiotech Inc. and Encourages Investors to Contact the Firm - Markets Insider

Jan 20, 2025
pulisher
Jan 18, 2025

XBIT Investors Have Opportunity to Join XBiotech Inc. Fraud Investigation with the Schall Law Firm - Kilgore News Herald

Jan 18, 2025
pulisher
Jan 15, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against XBiotech Inc. (XBIT) And Encourages Stockholders to Reach Out - Markets Insider

Jan 15, 2025
pulisher
Jan 15, 2025

Jane Street Group LLC Acquires Shares of 11,141 XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 15, 2025
pulisher
Jan 14, 2025

Wolf Haldenstein Adler Freeman & Herz LLP announces that it - GlobeNewswire

Jan 14, 2025
pulisher
Jan 14, 2025

Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating XBiotech for potential violations of securities laws - GlobeNewswire Inc.

Jan 14, 2025
pulisher
Jan 10, 2025

XBiotech Inc.'s (NASDAQ:XBIT) largest shareholders are individual investors with 49% ownership, insiders own 35% - Yahoo Finance

Jan 10, 2025
pulisher
Jan 07, 2025

Geode Capital Management LLC Acquires 22,059 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 07, 2025
pulisher
Jan 07, 2025

Barclays PLC Acquires 18,761 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 07, 2025
pulisher
Jan 02, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire

Jan 02, 2025
pulisher
Jan 02, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Walmart Inc.WMT - PR Newswire

Jan 02, 2025
pulisher
Jan 02, 2025

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XBiotech Inc.XBIT - PR Newswire

Jan 02, 2025
pulisher
Jan 02, 2025

State Street Corp Grows Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Jan 02, 2025
pulisher
Jan 02, 2025

XBiotech Inc. Appoints Dr. Tak W. Mak to its Board of Directors - Defense World

Jan 02, 2025
pulisher
Dec 31, 2024

XBiotech Appoints Renowned Scientist to Board of Directors - TipRanks

Dec 31, 2024
pulisher
Dec 31, 2024

Franklin Resources Inc. Trims Stock Holdings in JD.com, Inc. (NASDAQ:JD) - Defense World

Dec 31, 2024
pulisher
Dec 30, 2024

XBiotech (NASDAQ:XBIT) Has Debt But No Earnings; Should You Worry? - Simply Wall St

Dec 30, 2024
pulisher
Dec 27, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sana Biotechnology, Inc.SANA - PR Newswire

Dec 27, 2024
pulisher
Dec 27, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Joint Stock Company Kaspi.kzKSPI - PR Newswire

Dec 27, 2024
pulisher
Dec 27, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesCRBU - PR Newswire

Dec 27, 2024
pulisher
Dec 24, 2024

XBiotech halts all rheumatology research after missing Phase II endpoints - Yahoo Finance

Dec 24, 2024
pulisher
Dec 23, 2024

Stock market news: YSX Tech. -28.67%, XBiotech -24.76% among biggest losers during mid day trading - Business Upturn

Dec 23, 2024
pulisher
Dec 23, 2024

Another bump in the road for XBiotech and bermekimab - The Pharma Letter

Dec 23, 2024
pulisher
Dec 23, 2024

Xbiotech Shares Hit 52-Week Low on Halted Rheumatology Program - MarketWatch

Dec 23, 2024
pulisher
Dec 23, 2024

XBiotech Stock Hits 52-Week Low at $3.75 Amid Market Fluctuations - Investing.com

Dec 23, 2024
pulisher
Dec 23, 2024

Stock market today: XBiotech -31.66%, Nvni Group -31.59% among biggest losers in early trading - Business Upturn

Dec 23, 2024
pulisher
Dec 23, 2024

XBiotech trading resumes - Nasdaq

Dec 23, 2024
pulisher
Dec 23, 2024

XBiotech Halts Rheumatology Clinical Program - MarketWatch

Dec 23, 2024
pulisher
Dec 23, 2024

XBiotech Pauses Rheumatology program - GlobeNewswire

Dec 23, 2024
pulisher
Dec 23, 2024

XBiotech Halts Rheumatology Program After Major Data Irregularities Found in Phase 2 Trial - StockTitan

Dec 23, 2024
pulisher
Dec 22, 2024

Fmr LLC Has $224,000 Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Dec 22, 2024
pulisher
Dec 20, 2024

XBiotech Inc. (NASDAQ:XBIT) Stock Position Lifted by Charles Schwab Investment Management Inc. - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

(XBIT) Proactive Strategies - Stock Traders Daily

Dec 19, 2024
pulisher
Dec 16, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Holdings in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Dec 16, 2024
pulisher
Dec 11, 2024

12,157 Shares in XBiotech Inc. (NASDAQ:XBIT) Purchased by MetLife Investment Management LLC - Defense World

Dec 11, 2024
pulisher
Dec 11, 2024

XBiotech (NASDAQ:XBIT) vs. Ironwood Pharmaceuticals (NASDAQ:IRWD) Critical Analysis - Defense World

Dec 11, 2024
pulisher
Dec 08, 2024

(XBIT) Investment Analysis and Advice - Stock Traders Daily

Dec 08, 2024
pulisher
Nov 30, 2024

Connor Clark & Lunn Investment Management Ltd. Has $585,000 Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Nov 30, 2024
pulisher
Nov 28, 2024

Trend Tracker for (XBIT) - Stock Traders Daily

Nov 28, 2024
pulisher
Nov 25, 2024

Empowered Funds LLC Cuts Stock Position in XBiotech Inc. (NASDAQ:XBIT) - Defense World

Nov 25, 2024
pulisher
Nov 19, 2024

XBiotech (NASDAQ:XBIT) Stock Price Passes Below 50-Day Moving AverageHere's Why - MarketBeat

Nov 19, 2024
pulisher
Nov 19, 2024

Cancer Cachexia Market Demand, Segments, And Growth to 2033 Helsinn, Aphios, Eli Lilly, XBiotech - openPR

Nov 19, 2024
pulisher
Nov 17, 2024

How To Trade (XBIT) - Stock Traders Daily

Nov 17, 2024
pulisher
Nov 14, 2024

XBiotech: Q3 Earnings Snapshot - New Haven Register

Nov 14, 2024

Xbiotech Inc Azioni (XBIT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$80.20
price down icon 0.93%
$20.91
price up icon 1.45%
$356.69
price up icon 1.00%
$5.0799
price down icon 1.38%
biotechnology ONC
$228.63
price up icon 2.49%
$122.55
price up icon 4.61%
Capitalizzazione:     |  Volume (24 ore):